相关实验视频
Updated: May 8, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
诺阿克丁的新角色:干扰G-四重复在RET驱动的甲状腺髓癌中
Tariq Alqahtani1,2, Arwa Alsubait3,4, Meshari Aloumi5
1Department of Pharmaceutical Sciences, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Qahtanita@KSAU-hs.edu.sa.
BMC cancer
|December 23, 2024
概括
诺纳因通过向RET G-四重复结构,显示出对甲状腺中枢癌 (MTC) 的治疗潜力. 这种新的方法诱导了RET突变癌细胞的亡,为当前的氨酸激酶抑制剂 (TKI) 提供了替代方案.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 骨髓甲状腺癌 (MTC) 的发病与RET原基因突变有关.
- 目前对MTC的治疗方法 (TKI) 有局限性,包括副作用和耐药性.
- 作为一种抗菌化合物,诺纳丁因其在MTC治疗中的潜力而受到研究.
研究的目的:
- 为了研究诺纳克丁对MTC的疗效.
- 阐明诺纳克丁对RET原瘤基因的作用机制.
- 评估nonactin作为MTC新型治疗剂的潜力.
主要方法:
- 使用 luciferase 记者测试进行高通量选.
- 用诺纳克丁治疗MTC TT细胞系.
- 对RET蛋白和RNA水平,G-四重复合结,细胞循环和细胞亡的分析.
主要成果:
- 诺纳丁显著降低了RET促进剂活性.
- 诺纳丁在RET突变瘤细胞中选择性诱导了亡.
- 诺纳丁被证明与RET G-四重复区域结合.
结论:
- 诺纳丁通过RET G-四重复相互作用诱导MTC细胞的亡.
- 诺纳丁为MTC提供了一个有前途的治疗策略.
- 这种方法可以克服现有的氨酸激酶抑制剂的局限性.
相关概念视频
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Synthesis and Regulation of Thyroid Hormones
3.9K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
3.9K
Introduction to Actin
4.7K
Actin is a highly conserved cytoskeletal protein found abundantly in eukaryotic cells. It constitutes 10% weight of the total cellular protein in muscle cells, while in non-muscle cells, it is lower and makes up around 1–5 percent of the total cell protein. Actin found in the unicellular amoebae and complex multicellular animals is around 80% similar, demonstrating their conservation over a billion years of evolution. Actin coding genes are conserved within species and across...
4.7K
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K

